Using commercially available automated insulin delivery (AID) systems for treating type 1 diabetes during pregnancy remains controversial. This retrospective study assessed six pregnant women with type 1 diabetes who underwent AID therapy. Our observations revealed that AID treatment, in most cases, did not achieve the desired glycemic targets for pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.diabres.2023.110800 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!